It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 03975cam a22005057i 4500
001 2013444474
003 DLC
005 20140203131625.0
008 140130t20132013dcuab b 100 0 eng
010 $a 2013444474
016 7 $a101613693$2DNLM
020 $a9780309269445 (pbk.)
020 $a030926944X (pbk.)
035 $a(OCoLC)ocn830351870
040 $aNLM$beng$cNLM$erda$dYDXCP$dTEF$dCGU$dCUT$dOCLCO$dDLC
042 $anlmcopyc$alccopycat
050 00 $aRC270.8$b.D45 2013
060 00 $a2013 G-559
060 10 $aQZ 266
082 04 $a616.99406$223
111 2 $aDelivering Affordable Cancer Care in the 21st Century (Workshop)$d(2012 :$cWashington, D.C.),$jauthor.
245 10 $aDelivering Affordable Cancer Care in the 21st Century :$bworkshop summary /$cErin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bNational Academies Press,$c[2013]
264 4 $c©2013
300 $axiv, 80 pages :$billustrations (some color), color map ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 67-74).
505 0 $aIntroduction -- A financial crisis in health care -- Drivers of health care costs -- Cancer care costs -- Financial burden on patients with cancer -- Questionable value -- Current challenges -- Inappropriate incentives -- Unrealistic expectations -- Overuse and misuse of interventions -- Variable care, lack of best practices, and an inadequate evidence base -- Legal and regulatory issues -- Assessing value -- Possible solutions -- Patient and clinician communication and education -- Best practices in cancer care -- Evidence base for clinical practice and reimbursement -- Financial incentives aligned with affordable, high-quality cancer care -- Delivery system and reimbursement changes -- Wrap up.
520 $a"Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness. In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop"--$cPublisher's description.
650 0 $aCancer$xTreatment$vCongresses.
650 0 $aMedical care, Cost of$vCongresses.
650 0 $aMedical care$xFinance$vCongresses.
650 12 $aHealth Care Costs$zUnited States$vCongresses.
650 12 $aNeoplasms$xtherapy$zUnited States$vCongresses.
650 22 $aEvidence-Based Medicine$zUnited States$vCongresses.
650 22 $aHealth Services$xeconomics$zUnited States$vCongresses.
650 22 $aNeoplasms$xeconomics$zUnited States$vCongresses.
650 22 $aPractice Guidelines as Topic$zUnited States$vCongresses.
700 1 $aBalogh, Erin.
700 1 $aPatlak, Margie.
700 1 $aNass, Sharyl J.
710 2 $aNational Cancer Policy Forum (U.S.),$esponsoring body.
710 2 $aInstitute of Medicine (U.S.).$bBoard on Health Care Services,$eissuing body.